Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

Molecular Therapy 24,
1150 (June 2016). doi:10.1038/mt.2016.66

Authors: Anne M Noonan, Matthew R Farren, Susan M Geyer, Ying Huang, Sanaa Tahiri, Daniel Ahn, Sameh Mikhail, Kristen K Ciombor, Shubham Pant, Santiago Aparo, Jennifer Sexton, John L Marshall, Thomas A Mace, Christina S Wu, Bassel El-Rayes, Cynthia D Timmers, James Zwiebel, Gregory B Lesinski, Miguel A Villalona-Calero & Tanios S Bekaii-Saab

Source: Molecular Therapy - June 20, 2016 Category: Genetics & Stem Cells Authors: Anne M NoonanMatthew R FarrenSusan M GeyerYing HuangSanaa TahiriDaniel AhnSameh MikhailKristen K CiomborShubham PantSantiago AparoJennifer SextonJohn L MarshallThomas A MaceChristina S WuBassel El-RayesCynthia D TimmersJames ZwiebelGregory B LesinskiMigue Source Type: research